← Leaderboards
John Mellnik
Path Bioanalytics, Inc.
$1,925,387
Attributed
$1,925,387
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $800K · FY2016–18$1M$750K$500K$250K$0
'16
'17
'18
Funding mix
By agency
NIH$1,925,387 · 2
By mechanism
R44$1,599,984 · 1
R41$325,403 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Measurement”
- Lawrence Corey · Fred Hutchinson Cancer Center$517,278,507
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$468,973,477
- David R. Weir · University Of Michigan At Ann Arbor$403,695,976
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$297,689,086
- Christopher McKay · Battelle Memorial Institute$290,340,771
- David H Reitze · University Of Florida$256,180,831
Research focus
MeasurementNoseCystic Fibrosis Transmembrane Conductance RegulatorIn VivoMutantNasal EpitheliumCommercializationCystic Fibrosis PatientsEpithelialGenesMembraneMucous Body SubstanceMutationCell Culture TechniquesCombinatorialCellsBaseCystic FibrosisData AnalysesEffectivenessFaceFunctional RestorationMediatingOrganoids
Grant awards (3)
Human nasal epithelial organoids as a non-invasive, personalized model for predicting effectiveness of CFTR modulators in cystic fibrosis patients$799,989
R44 · FY2018 · HL · contact PI
Human nasal epithelial organoids as a non-invasive, personalized model for predicting effectiveness of CFTR modulators in cystic fibrosis patients$799,995
R44 · FY2017 · HL · contact PI
Human nasal epithelial organoids as a non-invasive, personalized model for predicting effectiveness of CFTR modulators in cystic fibrosis patients$325,403
R41 · FY2016 · HL · contact PI